Delivery Order SPE2DB24D6044-SPE2DB25FLJJF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,714.80 to AmerisourceBergen Drug Corp for the supply of Ampicillin 1 GM vials, with an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ampicillin-Sulbactam 3 GM vials on July 29, 2025. This competitively awarded, non-set-aside contract is valued at $1,666.78 with a firm fixed price structure and an ultimate completion date of July 30, 2025. The award represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,195,251 units of the antibiotic Ampicillin 2 GM ADD-VANTAGE VLS, with a ceiling value of $1,941.74. The contract is a firm fixed-price, non-set-aside award with a performance period through May 12, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a critical supplier of medical and...
- The Defense Logistics Agency Troop Support Medical awarded a $23,240 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 1,000 ampicillin 1 gram vials. The firm fixed price order is for delivery to a location in Conshohocken, Pennsylvania between July 20-21, 2023. No additional context was provided regarding the Defense Logistics Agency's programs or any associated contracts. The award information indicates this is a small order for pharmaceutical products to support...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,791.64 to AmerisourceBergen Drug Corp for the supply of Imipenem-Cilastatin 500 mg vials. This firm fixed-price delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.72 to AmerisourceBergen Drug Corp for Amoxicillin-Clavulanate 875-125 mg tablets (100 count) on August 14, 2025, with a completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $1,981.11 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This firm fixed-price contract, which must be completed by July 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,130.40 to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 4.5 GM vials. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, utilizes firm fixed-price contract terms and was competitively awarded without set-aside provisions. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,623.36 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJJFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ampicillin 1 GM vials with a ceiling value of $1,714.80. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 21, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company demonstrates significant capability in fulfilling federal medical supply needs through open competition, with its contract portfolio encompassing diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The Ampicillin delivery order reflects the company's ongoing role in supplying essential antibiotics and pharmaceutical commodities to support Defense Health Agency operations and broader U.S. military healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/20/25 |